Covid: UK Health Secretary Agency says seeing evidence of immune evasion with Omicron
|According to the UK Health Secretary Agency, there is evidence of immune evasion with the Omicron Covid-19 variant, according to Reuters. The agency said that two experiments show Omicron to have decreased lab neutralisation by 20 to 40 fold compared to the original virus, and by 10 to 20 fold compared to the Delta variant.
The agency added that the booster increases protection against mild disease to around 70-75% in a real-world study looking at 581 people with confirmed Omicron infection. However, the agency said that it was seeing reduced vaccine effectiveness for both the AstraZeneca and Pfizer jabs against mild disease with Omicron.
Market Reaction
Markets did not react to the latest data from the UK Health Secretary Agency.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.